Q'Apel Medical is focused on advancing neurovascular access technologies to improve stroke care. Their flagship products include the Balloon Catheter System, known as "Walrus," which addresses previous limitations of balloon-based variable stiffness catheters by offering enhanced performance. The Advanced Aspiration System, referred to as "Hippo," is designed for rapid and effective clot removal, featuring visible clot engagement to facilitate both typical and irregular cases. Additionally, the Neurovascular Access System, called "Armadillo," provides a unique balance of trackability and support, allowing operators to navigate complex neurovascular anatomy with greater control.

The company emphasizes innovation and responsiveness to the needs of neurovascular specialists, continuously developing solutions that tackle previously unsolvable technological challenges. Their commitment to excellence is reflected in their recent achievements, including the launch of the Armadillo platform and the awarding of a U.S. patent for their SelectFlex™ technology. Q'Apel Medical's products are designed to enhance the efficacy of stroke interventions, ultimately aiming to improve patient outcomes through cutting-edge medical technology.

United States

In the simplest sense, we're a company that creates solutions. More specifically, we design novel access device technology for neurovascular interventions and unmet clinical needs. Because in the precious seconds that surround a stroke emergency, clinicians need technology that delivers. That's where we come in.

Q'Apel Medical

Company Details